MX9305106A - Metodos para el tratamiento de cancer. - Google Patents

Metodos para el tratamiento de cancer.

Info

Publication number
MX9305106A
MX9305106A MX9305106A MX9305106A MX9305106A MX 9305106 A MX9305106 A MX 9305106A MX 9305106 A MX9305106 A MX 9305106A MX 9305106 A MX9305106 A MX 9305106A MX 9305106 A MX9305106 A MX 9305106A
Authority
MX
Mexico
Prior art keywords
methods
agent
cancer
treatment
mammal
Prior art date
Application number
MX9305106A
Other languages
English (en)
Inventor
Bangaru Chandrasekaran
David Stanley Duch
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of MX9305106A publication Critical patent/MX9305106A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención se refiere a métodos para el tratamiento de cáncer en un mamífero, los cuales incluyen administrar a este mamífero una cantidad potenciadora efectiva de AZT, ó una sal ó ester farmacéuticamente aceptable de la misma, con una cantidad efectiva de un agente de alquilación ó un agente de intercalación de DNA. El agente de alquilación preferido es melfalano, mientras que el agente de intercalación de DNA preferido es adríamicina.
MX9305106A 1992-08-24 1993-08-23 Metodos para el tratamiento de cancer. MX9305106A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929217998A GB9217998D0 (en) 1992-08-24 1992-08-24 Methods of treating cancer

Publications (1)

Publication Number Publication Date
MX9305106A true MX9305106A (es) 1994-03-31

Family

ID=10720879

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9305106A MX9305106A (es) 1992-08-24 1993-08-23 Metodos para el tratamiento de cancer.

Country Status (8)

Country Link
EP (1) EP0655918A1 (es)
JP (1) JPH08500356A (es)
AU (1) AU4967993A (es)
GB (1) GB9217998D0 (es)
IL (1) IL106763A0 (es)
MX (1) MX9305106A (es)
WO (1) WO1994004159A2 (es)
ZA (1) ZA936166B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002508758A (ja) * 1997-06-12 2002-03-19 エムエル・ラボラトリーズ・パブリック・リミテッド・カンパニー 生物的に活性な材料
US7951789B2 (en) * 2006-12-28 2011-05-31 Idenix Pharmaceuticals, Inc. Compounds and pharmaceutical compositions for the treatment of viral infections
EP2598128B1 (en) * 2010-07-28 2018-03-28 Life Technologies Corporation Anti- viral azide-containing compounds
EP3290038A4 (en) * 2015-04-30 2018-12-26 Taiho Pharmaceutical Co., Ltd. Agent for alleviating adverse reaction to antitumor drug
WO2018136920A1 (en) * 2017-01-23 2018-07-26 Health Research, Inc. Inhibition of endogenous reverse transcriptase and targeting of cells for prophylaxis and therapy of cancer and aging

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3821676A1 (de) * 1988-06-28 1990-02-08 Werner E G Prof Dr Mueller Verwendung von avaron oder avaron-derivaten in kombination mit 3'-azido-3'-deoxythymidin zur antiviralen therapie
US5116823A (en) * 1990-02-27 1992-05-26 Roger Williams General Hospital Drug combinations containing AZT

Also Published As

Publication number Publication date
IL106763A0 (en) 1993-12-08
WO1994004159A2 (en) 1994-03-03
ZA936166B (en) 1995-02-23
JPH08500356A (ja) 1996-01-16
AU4967993A (en) 1994-03-15
EP0655918A1 (en) 1995-06-07
GB9217998D0 (en) 1992-10-07
WO1994004159A3 (en) 1994-04-14

Similar Documents

Publication Publication Date Title
AR012671A1 (es) Composiciones farmaceuticas para el tratamiento o profilaxis de la constipacion, los usos de dichas composiciones y los procesos para prepararlos
MY119375A (en) Treatment of tinnitus using neuroprotective agents
AU7321598A (en) Use of cholinesterase inhibitors to treat disorders of attention
CA2370030A1 (en) Sodium channel blocker compositions and the use thereof
BR9809115A (pt) Métodos para tratar inflamação e doenças inflamatórias usando inibidores de padprt
FI880464A0 (fi) Bekaempningsmedel mot tandplaque och -karies.
UY26724A1 (es) Métodos y composiciones para tratar el virus de la hepatitis c
UA41355C2 (uk) Засіб для лікування нейро-сніду
GT199900015A (es) Procedimiento para tratar la insuficiencia cardiaca
ES2154693T3 (es) Combinacion de sustancias inductoras de necrosis con sustancias que son activadas por necrosis, para la terapia selectiva de tumores y enfermedades inflamatorias.
MX9302038A (es) Metodo para el tratamiento del cancer por una terapia conjunta con derivados de 2-halometilideno y un agente antineoplasico especifico de fase m o fase s.
ES2155093T3 (es) Nuevos inhibidores de la uridina fosforilasa (urdpasa) y de la dihidrouracil deshidrogenasa (dhudasa).
RU94002337A (ru) Фармацевтическая композиция, применение гамма-линоленовой или дигомо-гамма-линоленовой кислоты для лечения поражений после облучения, способ лечения
ES2180933T3 (es) Inhibidor de la serina-proteasa.
AR021912A1 (es) Uso de apomorfina para el tratamiento de la disfuncion erectil organica en varones
ECSP941082A (es) Procedimiento para la preparacion de la sal sodica cristalina adhidra de 5- cloro-3 (2-tenoli)-2- oxindol-1 carboxamida
BR8905657A (pt) Processo para preparar um quelante bifuncional,processo para preparar um complexo de um composto,processo para preparar um conjugado e processo para preparar uma formulacao farmaceutica
RU94037233A (ru) Применение 2-фенил-3-ароилбензотиофенов для лечения лекарственноустойчивых новообразований
MX9305106A (es) Metodos para el tratamiento de cancer.
BR0110396A (pt) Métodos para prevenir e tratar alopecia induzida por quimioterapia ou radioterapia
CO5060499A1 (es) Metodos y composiciones para el tratamiento de enfermedad de reflujo gastroesofagico
MX9400040A (es) Composiciones para tratar trastornos respiratorios.
MY104521A (en) Treatment of depression.
ES2186153T3 (es) Sulfato de 5-alfa-pregnan-3-beta-ol-20-ona para el tratamiento de tumores y de los trastornos del snc.
HK1028545A1 (en) Therapeutic formulations containing snake and/or insect venom for the prophylaxis and therapy of neoplasms